Paradigm BioCapital Advisors LP 13D and 13G filings for Oyster Point Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:59 pm Sale | 2022-12-31 | 13G | Oyster Point Pharma, Inc. OYST | Paradigm BioCapital Advisors LP | 0 0.000% | -1,462,576 (Position Closed) | Filing |
| 2022-07-18 4:24 pm Purchase | 2022-07-07 | 13G | Oyster Point Pharma, Inc. OYST | Paradigm BioCapital Advisors LP | 1,462,576 5.500% | 1,462,576 (New Position) | Filing |